TBRG vs. PCRX
TBRG (TruBridge Inc) and PCRX (Pacira BioSciences, Inc.) are both stocks. Both are in the Healthcare sector — TBRG in Health Information Services, PCRX in Drug Manufacturers - Specialty & Generic. Over the past 10 years, TBRG returned -3.55%/yr vs -3.59%/yr for PCRX. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
TBRG vs. PCRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TBRG achieves a 18.89% return, which is significantly higher than PCRX's 2.05% return. Both investments have delivered pretty close results over the past 10 years, with TBRG having a -3.55% annualized return and PCRX not far behind at -3.59%.
TBRG
- 1D
- 0.00%
- 1M
- 0.00%
- 6M
- 35.61%
- YTD
- 18.89%
- 1Y
- 27.75%
- 3Y*
- 2.33%
- 5Y*
- -3.79%
- 10Y*
- -3.55%
- ALL TIME*
- 4.32%
PCRX
- 1D
- -2.08%
- 1M
- 4.02%
- 6M
- 28.58%
- YTD
- 2.05%
- 1Y
- 19.66%
- 3Y*
- -9.81%
- 5Y*
- -14.84%
- 10Y*
- -3.59%
- ALL TIME*
- 8.95%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $14.03M | $12.91M | $12.23M |
TBRG vs. PCRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TBRG TruBridge Inc | 18.89% | 11.92% | 76.07% | -58.85% | -7.10% | 9.17% | 2.84% | 6.78% | -15.30% | 31.11% |
PCRX Pacira BioSciences, Inc. | 2.05% | 37.37% | -44.16% | -12.61% | -35.83% | 0.55% | 32.10% | 5.30% | -5.76% | 41.33% |
Correlation
The correlation between TBRG and PCRX is 0.10, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.10 |
Correlation (3Y) Balances recent behavior with more history. | 0.14 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.21 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.21 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2011 | 0.23 |
The correlation between TBRG and PCRX shifts across timeframes, from 0.10 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.
Fundamentals
TBRG:
$393.58M
PCRX:
$1.04B
TBRG:
$0.30
PCRX:
$0.22
TBRG:
87.27
PCRX:
121.47
TBRG:
1.10
PCRX:
1.54
TBRG:
2.14
PCRX:
1.65
TBRG:
$346.84M
PCRX:
$734.86M
TBRG:
$183.86M
PCRX:
$427.72M
TBRG:
$57.80M
PCRX:
$95.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TBRG vs. PCRX — Risk / Return Rank
TBRG
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
PCRX
TBRG vs. PCRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TruBridge Inc (TBRG) and Pacira BioSciences, Inc. (PCRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TBRG | PCRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.35 | ||
| Sortino ratioReturn per unit of downside risk | -0.30 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.14 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.35 | 0.86 | -0.50 |
| Martin ratioReturn relative to average drawdown | 1.00 | 1.85 | -0.85 |
Loading charts...
Drawdowns
TBRG vs. PCRX - Drawdown Comparison
The maximum TBRG drawdown since its inception was -86.87%, roughly equal to the maximum PCRX drawdown of -90.19%. Use the drawdown chart below to compare losses from any high point for TBRG and PCRX.
Loading charts...
Drawdown Indicators
| TBRG | PCRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.87% | -90.19% | +3.32% |
Max Drawdown (1Y)Largest decline over 1 year | -40.65% | -29.61% | -11.04% |
Max Drawdown (3Y)Largest decline over 3 years | -71.31% | -70.36% | -0.95% |
Max Drawdown (5Y)Largest decline over 5 years | -79.46% | -85.67% | +6.21% |
Max Drawdown (10Y)Largest decline over 10 years | -79.46% | -85.67% | +6.21% |
Current DrawdownCurrent decline from peak | -54.97% | -77.86% | +22.89% |
Average DrawdownAverage peak-to-trough decline | -35.89% | -50.30% | +14.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.38% | 13.70% | +0.68% |
Volatility
TBRG vs. PCRX - Volatility Comparison
The current volatility for TruBridge Inc (TBRG) is 0.41%, while Pacira BioSciences, Inc. (PCRX) has a volatility of 6.05%. This indicates that TBRG experiences smaller price fluctuations and is considered to be less risky than PCRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TBRG | PCRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.41% | 6.05% | -5.64% |
Volatility (6M)Calculated over the trailing 6-month period | 32.77% | 22.18% | +10.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.28% | 36.46% | +4.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.75% | 45.56% | -2.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.99% | 46.51% | -4.52% |
Dividends
TBRG vs. PCRX - Dividend Comparison
Neither TBRG nor PCRX has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TBRG TruBridge Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.12% | 1.52% | 1.59% | 2.83% | 7.88% | 5.15% |
Financials
TBRG vs. PCRX - Financials Comparison
This section allows you to compare key financial metrics between TruBridge Inc and Pacira BioSciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TBRG vs. PCRX - Profitability Comparison
TBRG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, TruBridge Inc reported a gross profit of 47.65M and revenue of 87.79M. Therefore, the gross margin over that period was 54.3%.
PCRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Pacira BioSciences, Inc. reported a gross profit of 0.00 and revenue of 177.38M. Therefore, the gross margin over that period was 0.0%.
TBRG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, TruBridge Inc reported an operating income of 4.98M and revenue of 87.79M, resulting in an operating margin of 5.7%.
PCRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Pacira BioSciences, Inc. reported an operating income of 6.90M and revenue of 177.38M, resulting in an operating margin of 3.9%.
TBRG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, TruBridge Inc reported a net income of -4.29M and revenue of 87.79M, resulting in a net margin of -4.9%.
PCRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Pacira BioSciences, Inc. reported a net income of 7.08M and revenue of 177.38M, resulting in a net margin of 4.0%.
Frequently Asked Questions
TBRG and PCRX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PCRX has higher volatility (6.05%) compared to TBRG (0.41%). In terms of maximum drawdown, TBRG dropped -86.87% vs PCRX's -90.19%.
PCRX currently has the higher Sharpe Ratio (0.70 vs 0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TBRG and PCRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer